Abbott Ends Patent Litigation With $234 Mil. Purchase Of Murex
This article was originally published in The Gray Sheet
Executive Summary
Abbott's $234 mil. acquisition of International Murex Technologies, announced March 16, forestalls a potentially costly patent trial that was expected to take place in mid-1998.